Jason C Wagner

Title: Jason C Wagner: Innovator in Thienopyrimidine Inhibitors

Introduction

Jason C Wagner is a notable inventor based in Coatesville, PA (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target atypical protein kinase C. With a total of six patents to his name, Wagner's work has the potential to impact the treatment of proliferative disorders.

Latest Patents

Wagner's latest patents focus on thienopyrimidine inhibitors of atypical protein kinase C. The present application provides a compound of formula (I) or a salt thereof, wherein R, R, R, R, R, R, A, G, M, Q, and X are as defined herein. These compounds exhibit PKC inhibitory activity and may be utilized in the treatment of various proliferative disorders. The innovative nature of these compounds highlights Wagner's commitment to advancing therapeutic options in the medical field.

Career Highlights

Throughout his career, Jason C Wagner has worked with prominent organizations such as Cancer Research Technology Limited and Cephalon, Inc. His experience in these companies has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of Wagner's notable coworkers include Keith S Learn and Gregory R Ott. Their collaborative efforts have further enhanced the research and development of innovative therapeutic compounds.

Conclusion

Jason C Wagner's contributions to the field of medicinal chemistry, particularly through his patents on thienopyrimidine inhibitors, demonstrate his dedication to improving treatment options for proliferative disorders. His work continues to inspire advancements in medical research and innovation.